Biofil Chemicals Intrinsic Value
BIOFILCHEM Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹39.60 | ₹31.68 - ₹47.52 | +22.5% | EPS: ₹1.80, Sector P/E: 22x |
| Book Value Method | asset | ₹23.75 | ₹21.38 - ₹26.13 | -26.5% | Book Value/Share: ₹11.88, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹57.50 | ₹51.75 - ₹63.25 | +77.9% | Revenue/Share: ₹28.75, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹25.00 | ₹22.50 - ₹27.50 | -22.7% | EBITDA: ₹4.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹16.98 | ₹13.58 - ₹20.38 | -47.5% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹28.80 | ₹25.92 - ₹31.68 | -10.9% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹29.03 | ₹26.13 - ₹31.93 | -10.2% | Revenue Growth: 15.0%, Adj P/E: 16.1x |
| ROE Based Valuation | profitability | ₹26.25 | ₹23.62 - ₹28.88 | -18.8% | ROE: 15.8%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹21.93 | ₹19.74 - ₹24.12 | -32.2% | EPS: ₹1.80, BVPS: ₹11.88 |
Want to compare with current market value? Check BIOFILCHEM share price latest .
Valuation Comparison Chart
BIOFILCHEM Intrinsic Value Analysis
What is the intrinsic value of BIOFILCHEM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Biofil Chemicals (BIOFILCHEM) is ₹26.25 (median value). With the current market price of ₹32.33, this represents a -18.8% variance from our estimated fair value.
The valuation range spans from ₹16.98 to ₹57.50, indicating ₹16.98 - ₹57.50.
Is BIOFILCHEM undervalued or overvalued?
Based on our multi-method analysis, Biofil Chemicals (BIOFILCHEM) appears to be trading above median value by approximately 18.8%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 2.68 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 15.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.90x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Biofil Chemicals
Additional stock information and data for BIOFILCHEM
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |